Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pilulka Lekarny AS's Enterprise Value is Kč346 Mil.
Pilulka Lekarny AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil. Therefore, Pilulka Lekarny AS's EV-to-EBIT ratio for today is .
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Pilulka Lekarny AS's Enterprise Value is Kč346 Mil.
Pilulka Lekarny AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil. Therefore, Pilulka Lekarny AS's EV-to-EBITDA ratio for today is .
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Pilulka Lekarny AS's Enterprise Value is Kč346 Mil.
Pilulka Lekarny AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was Kč1,304 Mil. Therefore, Pilulka Lekarny AS's EV-to-Revenue ratio for today is 0.26.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Pilulka Lekarny AS (XPRA:PINK) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil.
Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was Kč1,304 Mil.
Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil.
Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS Enterprise Value Related Terms
Pilulka Lekarny AS Enterprise Value Historical Data
* Premium members only.
The historical data trend for Pilulka Lekarny AS's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS Enterprise Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pilulka Lekarny AS Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Pilulka Lekarny AS's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Pilulka Lekarny AS's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pilulka Lekarny AS (XPRA:PINK) has a Enterprise Value of Kč346 Mil as of Jul. 08, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's Enterprise Value too high?
Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil. Overall, Pilulka Lekarny AS has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Enterprise Value compare to competitors?
Pilulka Lekarny AS's Enterprise Value of Kč346 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current Enterprise Value is Kč346 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč113.86, compared to a current price of Kč114.50 — trading 0.6% above its estimated fair value. The current Enterprise Value is Kč346 Mil. Pilulka Lekarny AS's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Enterprise Value is Kč346 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?
Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued.
The current stock price of Kč114.50 is trading 0.6% above its estimated GF Value™ of Kč113.86.
GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.
Key valuation signals for XPRA:PINK:
Enterprise Value: Kč346 Mil
GF Value™: Kč113.86 vs. price of Kč114.50 (0.6% above fair value)
No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
49GF Score
Get the complete analysis for XPRA:PINK
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPRA:PINK has been successfully added to your 